Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrew J Lewin
Linagliptin Added to Sulphonylurea in Uncontrolled Type 2 Diabetes Patients With Moderate-To-Severe Renal Impairment
Diabetes and Vascular Disease Research
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Related publications
Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pleiotropic Effects of Liraglutide in Patients With Type 2 Diabetes and Moderate Renal Impairment: Individual Effects of Treatment
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Prevalence of Undiagnosed Glucose Intolerance and Type 2 Diabetes in Patients With Moderate-To-Severe Obstructive Sleep Apnea Syndrome
Sleep and Breathing
Otorhinolaryngology
Neurology
Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience
Clinical Therapeutics
Pharmacology
A Review of Sitagliptin With Special Emphasis on Its Use in Moderate to Severe Renal Impairment
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Living With Moderate to Severe Renal Failure From the Perspective of Patients
BMC Nephrology
Nephrology
Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
